A detailed history of Financial Partners Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Partners Group, LLC holds 10,946 shares of NVO stock, worth $1.16 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
10,946
Previous 10,921 0.23%
Holding current value
$1.16 Million
Previous $1.56 Billion 16.39%
% of portfolio
0.49%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$119.07 - $145.42 $2,976 - $3,635
25 Added 0.23%
10,946 $1.3 Billion
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $409,115 - $489,797
3,334 Added 43.94%
10,921 $1.56 Billion
Q1 2024

Apr 17, 2024

SELL
$102.11 - $135.92 $106,602 - $141,900
-1,044 Reduced 12.1%
7,587 $974 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $3,247 - $3,901
37 Added 0.43%
8,631 $893 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $781,538 - $1.71 Million
8,594 New
8,594 $782 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Partners Group, LLC Portfolio

Follow Financial Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Partners Group, LLC with notifications on news.